Metastatic lymph node number in epithelial ovarian carcinoma: Does it have any clinical significance?

Gynecologic Oncology

Volumn 108, Issue 2, 2008, Pages 428-432

  Ayhan, Ali ^a   Gultekin, Murat ^b   Dursun, Polat ^a   Dogan, Nasuh Utku ^c   Aksan, Guldeniz ^c   Guven, Suleyman ^d   Velipasaoglu, Melih ^c   Yuce, Kunter ^c  

^a BASKENT UNIVERSITY   (Turkey)

^b Cankiri Government Hospital   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

^d KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Epithelial ovarian carcinoma; Lymphatic metastasis; Number of metastatic lymph node; Survival estimate

Indexed keywords

CA 125 ANTIGEN;

ADULT; ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OVARY CARCINOMA; PRIORITY JOURNAL; UNIVARIATE ANALYSIS; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; EPITHELIAL CELLS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 38649093328     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.09.014     Document Type: Article

References (11)

1. Ayhan A., Gultekin M., Taskiran C., Celik N.Y., Usubutun A., Kucukali T., et al. Lymphatic metastasis in epithelial ovarian carcinoma with respect to clinicopathological variables. Gynecol Oncol 97 2 (May 2005) 400-404
2. Panici P.B., Maggioni A., Hacker N., Landoni F., Ackermann S., Campagnutta E., et al. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial. J Natl Cancer Inst 97 8 (Apr 20 2005) 560-566
3. Burghardt E., Girardi F., Lahousen M., Tamussino K., and Stettner H. Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer. Gynecol Oncol 40 2 (Feb 1991) 103-106
4. Benedetti-Panici P., Greggi S., Maneschi F., Scambia G., Amoroso M., Rabitti C., et al. Anatomical and pathological study of retroperitoneal nodes in epithelial ovarian cancer. Gynecol Oncol 51 2 (Nov 1993) 150-154
5. Petru E., Lahousen M., Tamussino K., Pickel H., Stranzl H., Stettner H., et al. Lymphadenectomy in stage I ovarian cancer. Am J Obstet Gynecol 170 2 (Feb 1994) 656-662
6. di Re F., Baiocchi G., Fontanelli R., Grosso G., Cobellis L., Raspagliesi F., et al. Systematic pelvic and paraaortic lymphadenectomy for advanced ovarian cancer: prognostic significance of node metastases. Gynecol Oncol 62 3 (Sep 1996) 360-365
7. Onda T., Yoshikawa H., Yasugi T., Mishima M., Nakagawa S., Yamada M., et al. Patients with ovarian carcinoma upstaged to stage III after systematic lymphadenectomy have similar survival to Stage I/II patients and superior survival to other Stage III patients. Cancer 83 8 (Oct 15 1998) 1555-1560
8. Suzuki M., Ohwada M., Yamada T., Kohno T., Sekiguchi I., and Sato I. Lymph node metastasis in stage I epithelial ovarian cancer. Gynecol Oncol 79 2 (Nov 2000) 305-308
9. Morice P., Joulie F., Camatte S., Atallah D., Rouzier R., Pautier P., et al. Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications. J Am Coll Surg 197 2 (Aug 2003) 198-205
10. Creutzberg C.L. Lymphadenectomy in apparent early-stage endometrial carcinoma: do numbers count?. J Clin Oncol 23 16 (Jun 1 2005) 3653-3655
11. Chi D.S., Venkatraman E.S., Masson V., and Hoskins W.J. The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma. Gynecol Oncol 77 2 (May 2000) 227-231